BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29366419)

  • 1. Efficacy of Supplementation with Iron Sulfate Compared to Iron Bisglycinate Chelate in Preterm Infants.
    Bagna R; Spada E; Mazzone R; Saracco P; Boetti T; Cester EA; Bertino E; Coscia A
    Curr Pediatr Rev; 2018; 14(2):123-129. PubMed ID: 29366419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate.
    Ferrari P; Nicolini A; Manca ML; Rossi G; Anselmi L; Conte M; Carpi A; Bonino F
    Biomed Pharmacother; 2012 Sep; 66(6):414-8. PubMed ID: 22795809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial.
    Milman N; Jønsson L; Dyre P; Pedersen PL; Larsen LG
    J Perinat Med; 2014 Mar; 42(2):197-206. PubMed ID: 24152889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    Meyer MP; Haworth C; Meyer JH; Commerford A
    J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
    Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R
    J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial.
    Name JJ; Vasconcelos AR; Valzachi Rocha Maluf MC
    Curr Pediatr Rev; 2018; 14(4):261-268. PubMed ID: 30280670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials.
    Fischer JAJ; Cherian AM; Bone JN; Karakochuk CD
    Nutr Rev; 2023 Jul; 81(8):904-920. PubMed ID: 36728680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of oral iron bisglycinate to intravenous iron sucrose for the treatment of postpartum anemia-randomized controlled trial.
    Yefet E; Mruat Rabah S; Sela ND; Hosary Mhamed S; Yossef A; Nachum Z
    Am J Obstet Gynecol; 2021 Dec; 225(6):668.e1-668.e9. PubMed ID: 34171389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.
    Bader D; Blondheim O; Jonas R; Admoni O; Abend-Winger M; Reich D; Lanir A; Tamir A; Eldar I; Attias D
    Acta Paediatr; 1996 Apr; 85(4):496-501. PubMed ID: 8740313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteral iron supplementation in preterm and low birth weight infants.
    Mills RJ; Davies MW
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005095. PubMed ID: 22419305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Ferrous Bisglycinate and Folinic Acid in the Control of Iron Deficiency in Pregnant Women: A Randomized, Controlled Trial.
    Bumrungpert A; Pavadhgul P; Piromsawasdi T; Mozafari MR
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi.
    Nasir A; Yasmin H; Korejo R
    J Pak Med Assoc; 2011 Oct; 61(10):998-1001. PubMed ID: 22356035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy.
    Sanchez-Gonzalez LR; Castro-Melendez SE; Angeles-Torres AC; Castro-Cortina N; Escobar-Valencia A; Quiroga-Garza A
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():32-6. PubMed ID: 27566219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a Lower Dose of More Bioavailable Iron (18-mg Ferrous Bisglycinate) Noninferior to 60-mg Ferrous Sulfate in Increasing Ferritin Concentrations While Reducing Gut Inflammation and Enteropathogen Detection in Cambodian Women? A Randomized Controlled Noninferiority Trial.
    Fischer JAJ; Pei LX; Elango R; Hou K; Goldfarb DM; Karakochuk CD
    J Nutr; 2023 Aug; 153(8):2453-2462. PubMed ID: 37271416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants.
    Menendez C; Kahigwa E; Hirt R; Vounatsou P; Aponte JJ; Font F; Acosta CJ; Schellenberg DM; Galindo CM; Kimario J; Urassa H; Brabin B; Smith TA; Kitua AY; Tanner M; Alonso PL
    Lancet; 1997 Sep; 350(9081):844-50. PubMed ID: 9310602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism.
    Bechensteen AG; Halvorsen S; Hågå P; Cotes PM; Liestøl K
    Acta Paediatr; 1996 Apr; 85(4):490-5. PubMed ID: 8740312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy.
    Nazir S; Peverini RL; Deming DD; Hopper AO; Vyhmeister NR
    Arch Pediatr Adolesc Med; 2002 Jun; 156(6):540-4. PubMed ID: 12038884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effect of different dosage of recombinant human erythropoietin on anemia of premature infants.
    Chang L; Liu W; Liao C; Zhao X
    J Tongji Med Univ; 1998; 18(4):239-42. PubMed ID: 10806855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral iron supplementation in preterm infants treated with erythropoietin.
    Fujiu T; Maruyama K; Koizumi T
    Pediatr Int; 2004 Dec; 46(6):635-9. PubMed ID: 15660859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants.
    Kivivuori SM; Virtanen M; Raivio KO; Viinikka L; Siimes MA
    Eur J Pediatr; 1999 Feb; 158(2):147-51. PubMed ID: 10048613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.